Distinct p53 genomic binding patterns in normal and cancer-derived human cells

Cell Cycle

Volumn 10, Issue 24, 2011, Pages 4237-4249

  Botcheva, Krassimira ^a   McCorkle, Sean R ^a   McCombie, W R ^b   Dunn, John J ^a   Anderson, Carl W ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

ChIP seq; CpG island; P53; Transcription factor; Tumor suppressor; Whole genome binding

Indexed keywords

GENOMIC DNA; PROTEIN P53;

ARTICLE; BINDING SITE; CANCER CELL; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE MAPPING; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN CELL; MEDICAL DOCUMENTATION; PROTEIN BINDING; PROTEIN MOTIF; TRANSCRIPTION INITIATION SITE;

EID: 84055190692     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.24.18383     Document Type: Article

References (79)

1. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-22; PMID:19829295; http://dx.doi.org/10.1038/ nature08514.
2. Anderson CW, Appella E. Signaling to the p53 tumor suppressor through pathways activated by genotoxic and non-genotoxic stresses. In: Bradshaw RA, Dennis EA, Eds. Handbook of Cell Signaling: Elsevier 2009.
3. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395.
4. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609-22; PMID:19450511; http://dx.doi.org/10.1016/j.cell.2009.04.050.
5. Rinn JL, Huarte M. To repress or not to repress: This is the guardian's question. Trends Cell Biol 2011; 21:344-53; PMID:21601459; http://dx.doi.org/10. 1016/j.tcb.2011.04.002.
6. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9:749-58; PMID:19776744; http://dx.doi.org/10.1038/nrc2723.
7. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31; PMID:19410540; http://dx.doi.org/10.1016/j.cell. 2009.04.037.
8. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992; 1:45-9; PMID:1301998; http://dx.doi.org/10.1038/ng0492-45.
9. Funk WD, Pak DT, Karas RH, Wright WE, Shay JW. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 1992; 12:2866-71; PMID:1588974.
10. Jordan JJ, Menendez D, Inga A, Noureddine M, Bell DA, Resnick MA. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. PLoS Genet 2008; 4:1000104; PMID:18714371; http://dx.doi.org/10.1371/journal. pgen.1000104.
11. Kim E, Deppert W. The versatile interactions of p53 with DNA: when flexibility serves specificity. Cell Death Differ 2006; 13:885-9; PMID:16543936; http://dx.doi.org/10.1038/sj.cdd.4401909.
12. Bakhanashvili M, Hizi A, Rahav G. The interaction of p53 with 3'-terminal mismatched DNA. Cell Cycle 2010; 9:1380-9; PMID:20372060; http://dx.doi.org/10. 4161/cc.9.7.11201.
13. Weinberg RL, Veprintsev DB, Fersht AR. Cooperative binding of tetrameric p53 to DNA. J Mol Biol 2004; 341:1145-59; PMID:15321712; http://dx.doi.org/10. 1016/j.jmb.2004.06.071.
14. Schlereth K, Charles JP, Bretz AC, Stiewe T. Life or death: p53-induced apoptosis requires DNA binding cooperativity. Cell Cycle 2010; 9:4068-76; PMID:20948308; http://dx.doi.org/10.4161/cc.9.20.13595.
15. Petrovich M, Veprintsev DB. Effects of CpG methylation on recognition of DNA by the tumour suppressor p53. J Mol Biol 2009; 386:72-80; PMID:19084536; http://dx.doi.org/10.1016/j.jmb.2008.11.054.
16. Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 2002; 99:8467-72; PMID:12077306; http://dx.doi.org/10.1073/pnas. 132268899.
17. Horvath MM, Wang X, Resnick MA, Bell DA. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis. PLoS Genet 2007; 3:127; PMID:17677004; http://dx.doi.org/10.1371/journal.pgen.0030127.
18. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 2004; 116:499-509; PMID:14980218; http://dx.doi.org/10.1016/S0092-8674(04)00127-8.
19. Chen J, Sadowski I. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc Natl Acad Sci USA 2005; 102:4813-8; PMID:15781865; http://dx.doi.org/10.1073/pnas. 0407069102.
20. Hearnes JM, Mays DJ, Schavolt KL, Tang L, Jiang X, Pietenpol JA. Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators. Mol Cell Biol 2005; 25:10148-58; PMID:16260627; http://dx.doi.org/10.1128/MCB.25.22.10148-10158. 2005.
21. Kaneshiro K, Tsutsumi S, Tsuji S, Shirahige K, Aburatani H. An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 2007; 89:178-88; PMID:17085012; http://dx.doi.org/10.1016/j.ygeno.2006. 09.001.
22. Krieg AJ, Hammond EM, Giaccia AJ. Functional analysis of p53 binding under differential stresses. Mol Cell Biol 2006; 26:7030-45; PMID:16980608; http://dx.doi.org/10.1128/MCB.00322-06.
23. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-19; PMID:16413492; http://dx.doi.org/10.1016/j.cell.2005.10.043.
24. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, et al. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008; 36:3639-54; PMID:18474530; http://dx.doi.org/10.1093/nar/gkn232.
25. Smeenk L, van Heeringen SJ, Koeppel M, Gilbert B, Janssen-Megens E, Stunnenberg HG, et al. Role of p53 serine 46 in p53 target gene regulation. PLoS ONE 2011; 6:17574; PMID:21394211; http://dx.doi.org/10.1371/journal.pone. 0017574.
26. Dowell RD. Transcription factor binding variation in the evolution of gene regulation. Trends Genet 2010; 26:468-75; PMID:20864205; http://dx.doi.org/10.1016/j.tig.2010.08.005.
27. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92; PMID:17320506; http://dx.doi.org/10.1016/j.cell.2007.01.029.
28. Shaked H, Shiff I, Kott-Gutkowski M, Siegfried Z, Haupt Y, Simon I. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines. Cancer Res 2008; 68:9671-7; PMID:19047144; http://dx.doi.org/10.1158/0008-5472.CAN-08-0865.
29. Nichols WW, Murphy DG, Cristofalo VJ, Toji LH, Greene AE, Dwight SA. Characterization of a new human diploid cell strain, IMR-90. Science 1977; 196:60-3; PMID:841339; http://dx.doi.org/10.1126/science.841339.
30. Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 2009; 10:669-80; PMID:19736561; http://dx.doi.org/10.1038/nrg2641.
31. Rozowsky J, Euskirchen G, Auerbach RK, Zhang ZD, Gibson T, Bjornson R, et al. PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nat Biotechnol 2009; 27:66-75; PMID:19122651; http://dx.doi.org/10. 1038/nbt.1518.
32. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010; 22:1003-12; PMID:20100570; http://dx.doi.org/10.1016/j.cellsig.2010.01.013.
33. Nozell S, Chen X. p21B, a variant of p21Waf1/Cip1, is induced by the p53 family. Oncogene 2002; 21:1285-94; PMID:11850848; http://dx.doi.org/10.1038/sj. onc.1205191.
34. 3 receptor. Nucleic Acids Res 2006; 34:543-54; PMID:16434701; http://dx.doi.org/10.1093/nar/gkj460.
35. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142:409-19; PMID:20673990; http://dx.doi.org/10.1016/j.cell.2010.06.040.
36. Millau JF, Bastien N, Bouchard EF, Drouin R. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter. Cancer Res 2009; 69:8463-71; PMID:19843844; http://dx.doi.org/10.1158/0008-5472.CAN-09-2036.
37. Millau JF, Bandele OJ, Perron J, Bastien N, Bouchard EF, Gaudreau L, et al. Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements. Nucleic Acids Res 2011; 39:3053-63; PMID:21177650; http://dx.doi.org/10.1093/nar/ gkq1209.
38. Wang B, Xiao Z, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci USA 2009; 106:14373-8; PMID:19597154; http://dx.doi.org/10.1073/pnas. 0903284106.
39. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 2005; 6:21-31; PMID:15688064; http://dx.doi.org/10.1038/nrm1550.
40. Rahman-Roblick R, Johannes Roblick U, Hellman U, Conrotto P, Liu T, Becker S, et al. p53 targets identified by protein expression profiling. Proc Natl Acad Sci USA 2007; 104:5401-6; PMID:17372198; http://dx.doi.org/10.1073/ pnas.0700794104.
41. Cougot N, Babajko S, Séraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 2004; 165:31-40; PMID:15067023; http://dx.doi.org/10.1083/jcb.200309008.
42. Barbier J, Dutertre M, Bittencourt D, Sanchez G, Gratadou L, de la Grange P, et al. Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways. Mol Cell Biol 2007; 27:7315-33; PMID:17709397; http://dx.doi.org/10.1128/MCB.00272-07.
43. Boni V, Bitarte N, Cristobal I, Zarate R, Rodriguez J, Maiello E, et al. miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 2010; 9:2265-75; PMID:20647341; http://dx.doi.org/ 10.1158/1535-7163.MCT-10-0061.
44. Lee Y, Chen Y, Chang LS, Johnson LF. Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein. Exp Cell Res 1997; 234:270-6; PMID:9260894; http://dx.doi.org/10.1006/excr.1997. 3605.
45. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 2009; 33:717-26; PMID:19217333; http://dx.doi.org/10.1016/j.molcel.2009.01.026.
46. Chen LL, Carmichael GG. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell 2009; 35:467-78; PMID:19716791; http://dx.doi.org/10. 1016/j.molcel.2009.06.027.
47. Mao YS, Sunwoo H, Zhang B, Spector DL. Direct visualization of the co-transcriptional assembly of a nuclear body by noncoding RNAs. Nat Cell Biol 2011; 13:95-101; PMID:21170033; http://dx.doi.org/10.1038/ncb2140.
48. Zemojtel T, Kielbasa SM, Arndt PF, Chung HR, Vingron M. Methylation and deamination of CpGs generate p53-binding sites on a genomic scale. Trends Genet 2009; 25:63-6; PMID:19101055; http://dx.doi.org/10.1016/j.tig.2008.11.005.
49. Cui F, Sirotin MV, Zhurkin VB. Impact of Alu repeats on the evolution of human p53 binding sites. Biol Direct 2011; 6:2; PMID:21208455; http://dx.doi.org/10.1186/1745-6150-6-2.
50. Chen LL, DeCerbo JN, Carmichael GG. Alu element-mediated gene silencing. EMBO J 2008; 27:1694-705; PMID:18497743; http://dx.doi.org/10.1038/emboj.2008. 94.
51. Ashur-Fabian O, Har-Zahav A, Shaish A, Wiener Amram H, Margalit O, Weizer-Stern O, et al. apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53. Cell Cycle 2010; 9:3761-70; PMID:20890106; http://dx.doi.org/10.4161/cc.9.18.12993.
52. Puzio-Kuter AM, Levine AJ. Stem cell biology meets p53. Nat Biotechnol 2009; 27:914-5; PMID:19816447; http://dx.doi.org/10.1038/nbt1009-914.
53. Veprintsev DB, Fersht AR. Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA. Nucleic Acids Res 2008; 36:1589-98; PMID:18234719; http://dx.doi.org/10.1093/nar/gkm1040.
54. Riley T, Yu X, Sontag E, Levine A. The p53HMM algorithm: using profile hidden markov models to detect p53-responsive genes. BMC Bioinformatics 2009; 10:111; PMID:19379484; http://dx.doi.org/10.1186/1471-2105-10-111.
55. Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM. An abundance of bidirectional promoters in the human genome. Genome Res 2004; 14:62-6; PMID:14707170; http://dx.doi.org/10.1101/gr.1982804.
56. Hofer-Warbinek R, Schmid JA, Mayer H, Winsauer G, Orel L, Mueller B, et al. A highly conserved proapoptotic gene, IKIP, located next to the APAF1 gene locus, is regulated by p53. Cell Death Differ 2004; 11:1317-25; PMID:15389287; http://dx.doi.org/10.1038/sj.cdd.4401502.
57. Cho YJ, Liang P. Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci USA 2008; 105:5396-401; PMID:18385383; http://dx.doi.org/10.1073/pnas.0705410105.
58. Comer KA, Dennis PA, Armstrong L, Catino JJ, Kastan MB, Kumar CC. Human smooth muscle ?-actin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene 1998; 16:1299-308; PMID:9546431; http://dx.doi.org/10.1038/sj.onc.1201645.
59. Yang MQ, Elnitski LL. A computational study of bidirectional promoters in the human genome. Lect Notes Comput Sci 2007; 4463:361-71; PMID:20333320; http://dx.doi.org/10.1007/978-3-540-72031-7-33.
60. Millau JF, Mai S, Bastien N, Drouin R. p53 functions and cell lines: have we learned the lessons from the past? Bioessays 2010; 32:392-400; PMID:20414897; http://dx.doi.org/10.1002/bies.200900160.
61. Euskirchen GM, Rozowsky JS, Wei CL, Lee WH, Zhang ZD, Hartman S, et al. Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res 2007; 17:898-909; PMID:17568005; http://dx.doi.org/10.1101/gr.5583007.
62. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011; 25:1010-22; PMID:21576262; http://dx.doi.org/10.1101/gad.2037511.
63. Illingworth RS, Gruenewald-Schneider U, Webb S, Kerr ARW, James KD, Turner DJ, et al. Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet 2010; 6:1001134; PMID:20885785; http://dx.doi.org/10.1371/journal.pgen.1001134.
64. Mancini DN, Singh SM, Archer TK, Rodenhiser DI. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 1999; 18:4108-19; PMID:10435592; http://dx.doi.org/10.1038/sj.onc.1202764.
65. Renda M, Baglivo I, Burgess-Beusse B, Esposito S, Fattorusso R, Felsenfeld G, et al. Critical DNA binding interactions of the insulator protein CTCF: a small number of zinc fingers mediate strong binding, and a single finger-DNA interaction controls binding at imprinted loci. J Biol Chem 2007; 282:33336-45; PMID:17827499; http://dx.doi.org/10.1074/jbc.M706213200.
66. Nabilsi NH, Broaddus RR, Loose DS. DNA methylation inhibits p53-mediated survivin repression. Oncogene 2009; 28:2046-50; PMID:19363521; http://dx.doi.org/10.1038/onc.2009.62.
67. Choy JS, Wei S, Lee JY, Tan S, Chu S, Lee TH. DNA methylation increases nucleosome compaction and rigidity. J Am Chem Soc 2010; 132:1782-3; PMID:20095602; http://dx.doi.org/10.1021/ja910264z.
68. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 2007; 450:721-4; PMID:18046411; http://dx.doi.org/10.1038/ nature05993.
69. Menendez D, Shatz M, Azzam K, Garantziotis S, Fessler MB, Resnick MA. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 2011; 7:1001360; PMID:21483755; http://dx.doi.org/10.1371/ journal.pgen.1001360.
70. Bornstein C, Brosh R, Molchadsky A, Madar S, Kogan-Sakin I, Goldstein I, et al. SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63. Mol Cell Biol 2011; 31:1679-89; PMID:21300779; http://dx.doi.org/10.1128/MCB.01072-10.
71. Miyamoto Y, Kitamura N, Nakamura Y, Futamura M, Miyamoto T, Yoshida M, et al. Possible existence of lysosome-like organella within mitochondria and its role in mitochondrial quality control. PLoS ONE 2011; 6:16054; PMID:21264221; http://dx.doi.org/10.1371/journal.pone.0016054.
72. Illingworth RS, Bird AP. CpG islands - 'a rough guide'. FEBS Lett 2009; 583:1713-20; PMID:19376112; http://dx.doi.org/10.1016/j.febslet.2009.04.012.
73. Juven-Gershon T, Hsu JY, Theisen JWM, Kadonaga JT. The RNA polymerase II core promoter - the gateway to transcription. Curr Opin Cell Biol 2008; 20:253-9; PMID:18436437; http://dx.doi.org/10.1016/j.ceb.2008.03.003.
74. Morachis JM, Murawsky CM, Emerson BM. Regulation of the p53 transcriptional response by structurally diverse core promoters. Genes Dev 2010; 24:135-47; PMID:20040571; http://dx.doi.org/10.1101/gad.1856710.
75. Gomes NP, Espinosa JM. Differential regulation of p53 target genes: it's (core promoter) elementary. Genes Dev 2010; 24:111-4; PMID:20080948; http://dx.doi.org/10.1101/gad.1893610.
76. Tillo D, Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Field Y, et al. High nucleosome occupancy is encoded at human regulatory sequences. PLoS ONE 2010; 5:9129; PMID:20161746; http://dx.doi.org/10.1371/journal.pone.0009129.
77. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009; 138:114-28; PMID:19596239; http://dx.doi.org/10.1016/j.cell.2009.04.020.
78. Lidor Nili E, Field Y, Lubling Y, Widom J, Oren M, Segal E. p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancy. Genome Res 2010; 20:1361-8; PMID:20716666; http://dx.doi.org/10.1101/gr.103945. 109.
79. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473:43-9; PMID:21441907; http://dx.doi.org/10.1038/nature09906.